Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer A Systematic Review and Meta-analysis

被引:500
作者
Biagi, James J. [1 ]
Raphael, Michael J. [2 ]
Mackillop, William J. [1 ,2 ,3 ]
Kong, Weidong [2 ]
King, Will D. [3 ]
Booth, Christopher M. [1 ,2 ]
机构
[1] Queens Univ, Dept Oncol, Kingston, ON K7L 5P9, Canada
[2] Queens Univ, Div Canc Care & Epidemiol, Canc Res Inst, Kingston, ON K7L 5P9, Canada
[3] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON K7L 5P9, Canada
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2011年 / 305卷 / 22期
基金
加拿大健康研究院;
关键词
III COLON-CANCER; STAGE-II; PUBLICATION BIAS; RECTAL-CANCER; FLUOROURACIL; LEUCOVORIN; THERAPY; ANGIOGENESIS; RADIOTHERAPY; OXALIPLATIN;
D O I
10.1001/jama.2011.749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Adjuvant chemotherapy (AC) improves survival among patients with resected colorectal cancer. However, the optimal timing from surgery to initiation of AC is unknown. Objective To determine the relationship between time to AC and survival outcomes via a systematic review and meta-analysis. Data Sources MEDLINE (1975 through January 2011), EMBASE, the Cochrane Database of Systematic Reviews, and the Cochrane Central Register of Controlled Trials were searched to identify studies that described the relationship between time to AC and survival. Study Selection Studies were only included if the relevant prognostic factors were adequately described and either comparative groups were balanced or results adjusted for these prognostic factors. Data Extraction Hazard ratios (HRs) for overall survival and disease-free survival from each study were converted to a regression coefficient (beta) and standard error corresponding to a continuous representation per 4 weeks of time to AC. The adjusted beta from individual studies were combined using a fixed-effects model. Inverse variance (1/SE2) was used to weight individual studies. Publication bias was investigated using the trim and fill approach. Results We identified 10 eligible studies involving 15 410 patients (7 published articles, 3 abstracts). Nine of the studies were cohort or population based and 1 was a secondary analysis from a randomized trial of chemotherapy. Six studies reported time to AC as a binary variable and 4 as 3 or more categories. Meta-analysis demonstrated that a 4-week increase in time to AC was associated with a significant decrease in both overall survival (HR, 1.14; 95% confidence interval [CI], 1.10-1.17) and disease-free survival (HR, 1.14; 95% CI, 1.10-1.18). There was no significant heterogeneity among included studies. Results remained significant after adjustment for potential publication bias and when the analysis was repeated to exclude studies of largest weight. Conclusion In a meta-analysis of the available literature on time to AC, longer time to AC was associated with worse survival among patients with resected colorectal cancer.
引用
收藏
页码:2335 / 2342
页数:8
相关论文
共 46 条
  • [11] Biagi JJ, 2007, 2007 AM SOC CLIN ONC
  • [12] A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer
    Chau, I
    Norman, AR
    Cunningham, D
    Tait, D
    Ross, PJ
    Iveson, T
    Hill, M
    Hickish, T
    Lofts, F
    Jodrell, D
    Webb, A
    Oates, JR
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (04) : 549 - 557
  • [13] The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature
    Chen, Zheng
    King, Will
    Pearcey, Robert
    Kerba, Marc
    Mackillop, William J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 87 (01) : 3 - 16
  • [14] Etiology of Delays in the Initiation of Adjuvant Chemotherapy and Their Impact on Outcomes for Stage II and III Rectal Cancer
    Cheung, Winson Y.
    Neville, Bridget A.
    Earle, Craig C.
    [J]. DISEASES OF THE COLON & RECTUM, 2009, 52 (06) : 1054 - 1063
  • [15] Czaykowski P, 2007, 2007 AM SOC CLIN ONC
  • [16] Phenotypic characterization of human colorectal cancer stem cells
    Dalerba, Piero
    Dylla, Scott J.
    Park, In-Kyung
    Liu, Rui
    Wang, Xinhao
    Cho, Robert W.
    Hoey, Timothy
    Gurney, Austin
    Huang, Emina H.
    Simeone, Diane M.
    Shelton, Andrew A.
    Parmiani, Giorgio
    Castelli, Chiara
    Clarke, Michael F.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (24) : 10158 - 10163
  • [17] Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis
    Des Guetz, Gaetan
    Nicolas, Patrick
    Perret, Gerard-Yves
    Morere, Jean-Francois
    Uzzan, Bernard
    [J]. EUROPEAN JOURNAL OF CANCER, 2010, 46 (06) : 1049 - 1055
  • [18] A nonparametric "trim and fill" method of accounting for publication bias in meta-analysis
    Duval, S
    Tweedie, R
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2000, 95 (449) : 89 - 98
  • [19] Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
    Duval, S
    Tweedie, R
    [J]. BIOMETRICS, 2000, 56 (02) : 455 - 463
  • [20] Bias in meta-analysis detected by a simple, graphical test
    Egger, M
    Smith, GD
    Schneider, M
    Minder, C
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109): : 629 - 634